Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.2041
+0.0101 (5.21%)
At close: Nov 4, 2026, 4:00 PM EST
0.2077
+0.0036 (1.76%)
After-hours: Nov 4, 2026, 7:34 PM EST
Context Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 42.99 | 54.53 | 66 | 76.94 | 83.52 | 89.35 | 94.43 | 84.8 | 101.54 | 10.09 | 14.45 | 21.68 | 25.14 | 29.77 | 35.5 | 39.43 | 42.92 | 45.73 | 49.64 | 0.42 |
Cash & Short-Term Investments | 42.99 | 54.53 | 66 | 76.94 | 83.52 | 89.35 | 94.43 | 84.8 | 101.54 | 10.09 | 14.45 | 21.68 | 25.14 | 29.77 | 35.5 | 39.43 | 42.92 | 45.73 | 49.64 | 0.42 |
Cash Growth (YoY) | -48.52% | -38.97% | -30.11% | -9.27% | -17.75% | 785.62% | 553.50% | 291.20% | 303.92% | -66.11% | -59.29% | -45.02% | -41.43% | -34.90% | -28.48% | 9306.40% | 3254.00% | 2654.20% | 16976.13% | - |
Prepaid Expenses | 2.63 | 3.79 | 2.16 | 1.92 | 3.23 | 3.18 | 3.27 | 1.27 | 1.16 | 0.95 | 1.6 | 1.29 | 2.57 | 2.12 | 2.36 | 2.51 | 1.58 | 1.13 | 1.62 | 0.02 |
Other Current Assets | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Current Assets | 45.82 | 58.52 | 68.35 | 79.06 | 86.95 | 92.73 | 97.9 | 86.07 | 102.7 | 11.04 | 16.05 | 22.97 | 27.71 | 31.89 | 37.85 | 41.94 | 44.5 | 46.86 | 51.26 | 0.44 |
Property, Plant & Equipment | 0.32 | 0.34 | 0.14 | 0.17 | 0.2 | 0.23 | 0.23 | 0.26 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.05 | 0.08 | 0.1 | 0.13 | 0.15 | - | - |
Long-Term Deferred Charges | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.82 |
Other Long-Term Assets | - | - | - | - | - | - | - | - | - | - | - | - | 0.02 | 0.03 | 0.03 | 0.04 | 0.07 | 0.02 | 0.05 | - |
Total Assets | 46.13 | 58.86 | 68.49 | 79.23 | 87.15 | 92.97 | 98.13 | 86.33 | 102.71 | 11.05 | 16.06 | 22.99 | 27.76 | 31.97 | 37.97 | 42.08 | 44.7 | 47.03 | 51.31 | 2.26 |
Liabilities
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Accounts Payable | 3.29 | 2.47 | 2.53 | 2.72 | 2.4 | 1 | 1.45 | 1.03 | 0.61 | 2.05 | 2.38 | 1.83 | 1.19 | 1.21 | 0.94 | 1.49 | 0.95 | 0.45 | 1.83 | 3.08 |
Accrued Expenses | 4.41 | 2.99 | 5.34 | 3.16 | 2.01 | 0.71 | 1.14 | 1.11 | 0.98 | 0.55 | 1.8 | 2.72 | 2.54 | 1.95 | 2.13 | 2.38 | 1.95 | 1.03 | 1.12 | 1.33 |
Current Portion of Leases | 0.17 | 0.16 | 0.11 | 0.12 | 0.11 | 0.11 | 0.11 | 0.1 | - | - | - | - | 0.01 | 0.03 | 0.06 | 0.08 | 0.09 | 0.09 | - | - |
Other Current Liabilities | 0.02 | 0.92 | 0.04 | 0.03 | 0.04 | 0.08 | 0.05 | 0.09 | 0.01 | 0.01 | 0.01 | 0.06 | 0.02 | 0.04 | 0.08 | 0.06 | 0.05 | 0.03 | 0.09 | - |
Total Current Liabilities | 7.88 | 6.53 | 8.02 | 6.04 | 4.56 | 1.9 | 2.75 | 2.33 | 1.6 | 2.61 | 4.19 | 4.6 | 3.76 | 3.23 | 3.21 | 4.01 | 3.04 | 1.61 | 3.03 | 4.41 |
Long-Term Leases | 0.08 | 0.12 | - | 0.02 | 0.05 | 0.08 | 0.11 | 0.14 | - | - | - | - | - | - | - | - | 0.01 | 0.03 | - | - |
Other Long-Term Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.08 |
Total Liabilities | 7.96 | 6.66 | 8.02 | 6.06 | 4.61 | 1.98 | 2.86 | 2.47 | 1.6 | 2.61 | 4.19 | 4.6 | 3.76 | 3.23 | 3.21 | 4.01 | 3.05 | 1.64 | 3.03 | 4.49 |
Shareholders' Equity
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Common Stock | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.07 | 0.07 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0 |
Additional Paid-In Capital | 192.22 | 191.69 | 191.29 | 190.96 | 190.64 | 190.25 | 189.96 | 175.22 | 175.01 | 80.15 | 79.91 | 79.65 | 79.4 | 79.12 | 78.83 | 78.59 | 78.31 | 78.07 | 77.51 | 2.95 |
Retained Earnings | -154.14 | -139.58 | -130.9 | -117.88 | -108.18 | -99.36 | -94.78 | -91.44 | -73.98 | -71.72 | -68.05 | -61.28 | -55.41 | -50.4 | -44.09 | -40.53 | -36.68 | -32.69 | -29.25 | -26.16 |
Total Common Equity | 38.17 | 52.2 | 60.47 | 73.17 | 82.54 | 90.98 | 95.27 | 83.86 | 101.1 | 8.44 | 11.87 | 18.38 | 24 | 28.73 | 34.76 | 38.07 | 41.65 | 45.39 | 48.27 | -23.21 |
Shareholders' Equity | 38.17 | 52.2 | 60.47 | 73.17 | 82.54 | 90.98 | 95.27 | 83.86 | 101.1 | 8.44 | 11.87 | 18.38 | 24 | 28.73 | 34.76 | 38.07 | 41.65 | 45.39 | 48.27 | -2.23 |
Total Liabilities & Equity | 46.13 | 58.86 | 68.49 | 79.23 | 87.15 | 92.97 | 98.13 | 86.33 | 102.71 | 11.05 | 16.06 | 22.99 | 27.76 | 31.97 | 37.97 | 42.08 | 44.7 | 47.03 | 51.31 | 2.26 |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Total Debt | 0.24 | 0.28 | 0.11 | 0.14 | 0.17 | 0.19 | 0.22 | 0.24 | - | - | - | - | 0.01 | 0.03 | 0.06 | 0.08 | 0.1 | 0.12 | - | - |
Net Cash (Debt) | 42.75 | 54.25 | 65.88 | 76.8 | 83.35 | 89.16 | 94.21 | 84.56 | 101.54 | 10.09 | 14.45 | 21.68 | 25.13 | 29.74 | 35.44 | 39.35 | 42.82 | 45.6 | 49.64 | 0.42 |
Net Cash Growth (YoY) | -48.72% | -39.16% | -30.07% | -9.18% | -17.91% | 783.70% | 551.98% | 290.08% | 304.05% | -66.07% | -59.23% | -44.91% | -41.31% | -34.79% | -28.59% | 9287.74% | 3605.30% | 2868.55% | - | - |
Net Cash Per Share | 0.45 | 0.57 | 0.69 | 0.81 | 0.88 | 0.94 | 1.15 | 1.05 | 1.85 | 0.63 | 0.91 | 1.36 | 1.57 | 1.86 | 2.22 | 2.46 | 2.68 | 2.86 | 4.83 | 1.16 |
Filing Date Shares Outstanding | 91.88 | 91.88 | 91.88 | 91.88 | 89.7 | 89.7 | 89.7 | 75 | 75 | 75 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 10.96 |
Total Common Shares Outstanding | 91.88 | 91.88 | 91.88 | 91.88 | 89.7 | 89.7 | 89.7 | 75 | 75 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 | 0.35 |
Working Capital | 37.93 | 51.98 | 60.33 | 73.02 | 82.39 | 90.83 | 95.15 | 83.74 | 101.09 | 8.43 | 11.86 | 18.37 | 23.95 | 28.65 | 34.65 | 37.93 | 41.46 | 45.25 | 48.22 | -3.97 |
Book Value Per Share | 0.42 | 0.57 | 0.66 | 0.80 | 0.92 | 1.01 | 1.06 | 1.12 | 1.35 | 0.53 | 0.74 | 1.15 | 1.50 | 1.80 | 2.18 | 2.38 | 2.61 | 2.84 | 3.02 | -66.61 |
Tangible Book Value | 38.17 | 52.2 | 60.47 | 73.17 | 82.54 | 90.98 | 95.27 | 83.86 | 101.1 | 8.44 | 11.87 | 18.38 | 24 | 28.73 | 34.76 | 38.07 | 41.65 | 45.39 | 48.27 | -23.21 |
Tangible Book Value Per Share | 0.42 | 0.57 | 0.66 | 0.80 | 0.92 | 1.01 | 1.06 | 1.12 | 1.35 | 0.53 | 0.74 | 1.15 | 1.50 | 1.80 | 2.18 | 2.38 | 2.61 | 2.84 | 3.02 | -66.61 |